VX12-809-103: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosi

Project: Research project

Project Details

StatusFinished
Effective start/end date5/29/13 → 5/29/15

Funding

  • Vertex Pharmaceuticals Incorporated